NASDAQ : NTRB
Nutriband Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 6.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 80.71M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 76.58M |
| Enterprise Value | 73.38M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.16M |
| Shares Outstanding | 12.16M |
| Shares Change (YoY) | +8.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 42.58% |
| Owned by Institutions (%) | 3.13% |
| Float | 5.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 47.34 |
| Forward PS | n/a |
| PB Ratio | 14.38 |
| P/TBV Ratio | 22.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 45.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.21 |
| Quick Ratio | 3.80 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -255.59 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -100.75% |
| Return on Assets (ROA) | -53.48% |
| Return on Invested Capital (ROIC) | -61.54% |
| Return on Capital Employed (ROCE) | -130.82% |
| Weighted Average Cost of Capital (WACC) | 14.85% |
| Revenue Per Employee | $124,437 |
| Profits Per Employee | -$535,611 |
| Employee Count | 13 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 7.01 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.93 |
| 52-Week Price Change | -9.09% |
| 50-Day Moving Average | 6.36 |
| 200-Day Moving Average | 4.37 |
| Relative Strength Index (RSI) | 49.71 |
| Average Volume (20 Days) | 35,894 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 157,796 |
| Short Previous Month | 153,440 |
| Short % of Shares Out | 1.30% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 1.32 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.62M |
| Gross Profit | 536,121 |
| Operating Income | -7.05M |
| Pretax Income | -6.96M |
| Net Income | -6.96M |
| EBITDA | -6.90M |
| EBIT | -7.05M |
| Loss Per Share | -$0.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.42M |
| Total Debt | 219,719 |
| Net Cash | 3.20M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 5.33M |
| Book Value Per Share | 0.44 |
| Working Capital | 2.91M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -3.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 146,438 |
| Net Borrowing | -15,006 |
| Free Cash Flow | -3.63M |
| FCF Per Share | -$0.30 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.14% |
| Operating Margin | -435.58% |
| Pretax Margin | -430.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.93% |
| Shareholder Yield | -8.93% |
| Earnings Yield | -9.11% |
| FCF Yield | -4.74% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 297.17% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 12, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1666667:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 22.18 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |